Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Hemiplegic Migraine Treatment Study on the Reed Procedure® Offers Hope to Sufferers
  • USA - English


News provided by

Reed Migraine Centers

Feb 19, 2015, 10:35 ET

Share this article

Share toX

Share this article

Share toX

Dr. Ken Reed and Reed Migraine Treatment Center's Partner Physicians
Dr. Ken Reed and Reed Migraine Treatment Center's Partner Physicians
Youtube
Youtube

Dallas, TX (PRWEB) February 19, 2015 -- Reed Migraine Centers has announced the publication of a new research paper detailing the successful application of the Reed Procedure® in a series of patients suffering from the debilitating malady of hemiplegic migraine headaches. The study published in the medical journal “Neuromodulation” found that all 4 patients treated reported successful control of both their headaches and neurological symptoms, which allowed them to return to full normal daily activities, including work, sports and family life.

Absolutely all of the patients we treated reported success

Post this

“While rare, hemiplegic migraine is arguably the most severe form of migraine, as in addition to the severe headache, these patients suffer from weakness or paralysis over part of their body during the headache,” explained Dr. Reed. “In fact all of the patients in our study were so completely debilitated from their disease that they were not only unable to work, they frequently could not even attend family outings.”

Team member and co-author, Dr. Robert Bulger, described the impressive results of the therapy. “Absolutely all of the patients we treated reported success,” said Dr. Robert Bulger. “While we have seen excellent results before with the Reed Procedure®, it was particularly fulfilling to see such dramatic improvements in my patients suffering from such a devastating illness.”

Dr. Bulger put a human face on the study, when he described the dramatic response enjoyed by a recent patient of his. “Joan had reached the point of complete incapacitation and was virtually bedbound,” related Dr. Bulger. “So, imagine my pleasure as a physician, when I saw her back 6 months after treatment and found her wearing a big smile, as she emphasized to me that she was not just better – she was completely headache free - and in fact had just returned from a zip-lining adventure during a trip to Alaska. Before the implant, she could hardly get out of bed, and now my patient is living life to the fullest. This has been an amazing journey for all of us.”

Co-author, Dr. Kelly Will, emphasized the medical team’s continued success. “In addition to our study patients, we now have another patient with hemiplegic migraine who has had a positive response to a test stimulator,” said Dr. Will. “She had a great response to the initial test stimulator, as she was almost completely headache and symptom free for the entire period,” Dr. Will continued. “She and her husband are definitely looking forward to the upcoming permanent implant.”

Dr. Frank Conidi, a co-author with the Department of Neurology at Florida State University College of Medicine, emphasized the importance of the initial “test or trial” portion of the procedure, as despite the excellent results reported in the study, individual results for any patient may vary. “One of the many nice things about the Reed Procedure ® is the initial test stimulator phase,” said Dr. Conidi. “Our patients are pleased with this, as it allows them to actually test and see how well a stimulator will work for them, before they actually commit to the full procedure.”

The Reed Procedure ®, technically known as “Combined Occipital and Supraorbital Nerve Stimulation” was first described in a landmark paper published in 2010 in “Cephalalgia,” the Journal of the International Headache Society. The Society honored Dr. Reed with the prestigious “Cephalalgia Award” for the best original research contribution to the journal that year.

Lauren Smith, Director of Physician Services for Reed Migraine, indicated that Dr. Reed is currently holding weekly patient information webinars for those who would like more information on the Reed Procedure®. “I strongly recommend that patients attend one of our webinars to hear Dr. Reed personally discuss the full details of the treatment,” said Mrs. Smith. “Patients can register for an informational webinar on our website at http://reedmigraine.com/webinars.php?lt=42 .”;

About Reed Migraine Centers:
Reed Migraine Centers partners with the most respected pain management physicians in the world to offer advanced treatments, including the International Headache Society’s Cephalalgia Award winning Reed Procedure®, to help migraine suffers enjoy a better quality of life.

Lauren Smith, Reed Migraine Centers, http://www.reedmigraine.com, 972 707-2820, Lauren.Smith@reedmigraine.com

Modal title

The actual Reed Procedure for hemiplegic migraine paper.
View PDF
The actual Reed Procedure for hemiplegic migraine paper.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.